Drug pricing control order
-
Upload
ruqaiya-vasi -
Category
Healthcare
-
view
61 -
download
0
Transcript of Drug pricing control order
![Page 1: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/1.jpg)
IMPACT OF NLEM-2015 ON PHARMACEUTICAL INDUSTRY
PRESENTED BY:AMAN DUBE (QA-04)RIDDHI DESAI(QA-03)RUQAIYA VASI (QA-17)IAN FERNANDIS (QA-20)KANJANI SHAH(QA-15)
![Page 2: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/2.jpg)
NLEM 2015
The health ministry has revised its National List of Essential
Medicines (NLEM) to include 376 drugs in the new NLEM 2015 list.
While a total of 106 medicines have been added, 70 medicines have been deleted to finalize the
new list.
![Page 3: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/3.jpg)
VALUE LOST ON INCREMENTAL PRICES CAPPED AS PER REVISED NLEM LIST
![Page 4: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/4.jpg)
VOLUME GROWTH TRENDS
![Page 5: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/5.jpg)
PRICING GROWTH TRENDS
![Page 6: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/6.jpg)
EFFECT ON THERAPEUTIC CATEGORIES
![Page 7: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/7.jpg)
CIPLA SALES GROWTH TRENDS
![Page 8: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/8.jpg)
Source: IMS
![Page 9: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/9.jpg)
124%
217%
322%
419%
518%
ABACAVIR
12345
1 = 20112 = 20123 =20134 = 20145 = 2015
Source : IMS
112%
217%
320%
425%
527%
TENOFOVIR
12345
![Page 10: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/10.jpg)
REVENUE CONTRIBUTION OF MOLECULES OF CIPLA
Source: IMS
![Page 11: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/11.jpg)
Source : IMS
ANTICANCER DRUGS
INCLUDED IN NLEM 2015
![Page 12: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/12.jpg)
Comparison of Pfizer growth with other MNCs
IMPACT OF NLEM 2015 ON PFIZER
![Page 13: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/13.jpg)
Cardiac segment
Anti-infective segment Anti-infective segmentMolecule wise sales
Anti- diabetic segment
![Page 14: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/14.jpg)
ACUTE/ CHRONIC BREAK UP
![Page 15: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/15.jpg)
PRE-NLEM: Rise the price to harvest maximum profit.
POST-NLEM: If increase in volume will maintain the profit, then promotion should not be stopped.
Keep the margin same for distributor and retailer to maintain good relationship with them.
Start focusing on Semi regulated countries.
Product Line extension.
STRATERGY FOR PFIZER AND CIPLA
![Page 16: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/16.jpg)
MNC
![Page 17: Drug pricing control order](https://reader036.fdocuments.net/reader036/viewer/2022062904/587721851a28ab4c1d8b7ad7/html5/thumbnails/17.jpg)
Thank You